Please login to the form below

Not currently logged in
Email:
Password:

ASCO 2013

This page shows the latest ASCO 2013 news and features for those working in and with pharma, biotech and healthcare.

Have you got the adaptability factor?

Have you got the adaptability factor?

that at ASCO 2013, Tweets were up 300 per cent on 2011, #ASCO13 was trending worldwide and over 16, 000 tweets were posted –using said hash tag – by a mixture of ... founder of Big Eye Dear. 1st August 2013.

Latest news

  • ASCO: Boehringer's nintedanib boosts survival in lung cancer subset ASCO: Boehringer's nintedanib boosts survival in lung cancer subset

    Germany, who was the principal investigator in the trial and presented the data at ASCO. ... Meanwhile, a combination study looking at nintedanib in combination with Lilly's Alimta (pemetrexed) in non-squamous NSCLC, called LUME-Lung 2, was also

  • ASCO: Amgen says viral therapy for melanoma ASCO: Amgen says viral therapy for melanoma "encouraging"

    The results of the OPTiM study – reported at the American Society of Clinical Oncology (ASCO) meeting in Chicago – are a milestone as they represent the first time that a virus-based ... data at ASCO. Amgen said it is carrying out early-stage

  • ASCO: Merck and BMS trumpet melanoma trials ASCO: Merck and BMS trumpet melanoma trials

    at the American Society of Clinical Oncology (ASCO) conference in Chicago, US,  over the weekend as optimism builds for the new drug class. ... The NEJM published another study (also presented at ASCO) in which nivolumab was combined with Yervoy to

  • Late-stage failure for Merck’s cilengitide in brain cancer Late-stage failure for Merck’s cilengitide in brain cancer

    Merck said detailed trial results will be submitted for presentation at the American Society of Clinical Oncology (ASCO) 2013 Annual Meeting and publication in a peer-reviewed journal. ... 25th February 2013.

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics